Availability: Άμεσα Διαθέσιμο

Kucers’ The Use of Antibiotics – 3 volume set

A Clinical Review of Antibacterial, Antifungal, Antiparasitic, a

ISBN: 9781498747950
Εκδόσεις:
Εκδόσεις

Ημ. Έκδοσης

2017/02

Σελίδες

5338

Μορφή

Έντυπο

Συγγραφείς

, , , , , ,

Κύριος Συγγραφέας

541,00€(Περιλαμβάνεται ΦΠΑ 6%)

A Clinical Review of Antibacterial, Antifungal, Antiparasitic, a

Διαθεσιμότητα: 23-28 ημέρες

Περιγραφή

Features

  • The definitive major reference work in the field, covering key information that the infectious diseases specialist will need to know about antimicrobial drugs
  • Comprehensive coverage of the drug available, including those new to the market and, importantly, those currently under trial
  • Highly standardized content, structured for ease of reference
  • Globally applicable, compiled by an international team of expert editors and contributors
  • Added to this edition – new antivirals, particularly the highly effective compounds now available to treat HIV and viral hepatitis; new antibiotics – beta-lactamase inhibitors and cephalosporins, quinolones and fluoroquinolones, anti-tuberculosis agents; plus new antifungals and antiparasitics
  • Summary

    Kucers The Use of Antibiotics is the definitive, internationally-authored reference, providing everything that the infectious diseases specialist and prescriber needs to know about antimicrobials in this vast and rapidly developing field. The much-expanded Seventh Edition comprises 4800 pages in 3 volumes in order to cover all new and existing therapies, and emerging drugs not yet fully licensed. Concentrating on the treatment of infectious diseases, the content is divided into four sections – antibiotics, anti-fungal drugs, anti-parasitic drugs, and anti-viral drugs – and is highly structured for ease of reference.

    Each chapter is organized in a consistent format, covering susceptibility, formulations and dosing (adult and pediatric), pharmacokinetics and pharmacodynamics, toxicity, and drug distribution, with detailed discussion regarding clinical uses – a feature unique to this title. Compiled by an expanded team of internationally renowned and respected editors, with expert contributors representing Europe, Africa, Asia, Australia, South America, the US, and Canada, the Seventh Edition adopts a truly global approach. It remains invaluable for anyone using antimicrobial agents in their clinical practice and provides, in a systematic and concise manner, all the information required when prescribing an antimicrobial to treat infection.

    Περιεχόμενα

    Foreword, Obituary: Dr. Alvis Kucers, Hail the Greats, Preface, Abbrieviations. SECTION I Introduction. SECTION II Antibiotics:

    Part 1 Penicillins and related drugs

    Part 2 Cephalosporins and related drugs

    Part 3 Carbapenems

    Part 4 Glycopeptides and lipopeptides

    Part 5 Aminoglycosides

    Part 6 Macrolides and Ketolides

    Part 7 Tetracyclines and related drugs

    Part 8 Other antibiotics

    Part 9 Anti-folate agents and other synthetic antibacterials

    Part 10 Nitroimidazoles

    Part 11 Quinolones and Fluoroquinolones.

    Part 12 Anti-tuberculosis drugs.

    SECTION III Antifungal drugs:
    Part 1 Polyenes

    Part 2 Echinocandins

    Part 3 Allylamines and benzylamine derivatives

    Part 4 Systemic azoles

    Part 5 Topical azoles
    Part 6 Topical agents—thiocarbomates, hydroxypyridones, and morpholine
    Part 7 Other antifungal agents.

    SECTION IV Antiparasitic drugs:
    Part 1 Anti-malarial drugs,

    Part 2 Agents active against intestinal and extra-intestinal protozoa

    Part 3 Agents active against American trypanosomiasis

    Part 4 Agents active against African trypanosomiasis

    Part 5 Agents active against leishmania and other pathogens

    Part 6 Agents active against helminths

    Part 7 Agents active against ectoparasites

    SECTION V Antiviral drugs:
    Part 1 Agents active against herpesviruses

    Part 2 Agents active against the human immunodeficiency virus, Part 3 Agents active against hepatitis viruses

    Part 4 Agents active against influenza viruses,

    Part 5 Investigational antiviral drugs.